Literature DB >> 25326273

Exercise in muscle glycogen storage diseases.

Nicolai Preisler1, Ronald G Haller, John Vissing.   

Abstract

Glycogen storage diseases (GSD) are inborn errors of glycogen or glucose metabolism. In the GSDs that affect muscle, the consequence of a block in skeletal muscle glycogen breakdown or glucose use, is an impairment of muscular performance and exercise intolerance, owing to 1) an increase in glycogen storage that disrupts contractile function and/or 2) a reduced substrate turnover below the block, which inhibits skeletal muscle ATP production. Immobility is associated with metabolic alterations in muscle leading to an increased dependence on glycogen use and a reduced capacity for fatty acid oxidation. Such changes may be detrimental for persons with GSD from a metabolic perspective. However, exercise may alter skeletal muscle substrate metabolism in ways that are beneficial for patients with GSD, such as improving exercise tolerance and increasing fatty acid oxidation. In addition, a regular exercise program has the potential to improve general health and fitness and improve quality of life, if executed properly. In this review, we describe skeletal muscle substrate use during exercise in GSDs, and how blocks in metabolic pathways affect exercise tolerance in GSDs. We review the studies that have examined the effect of regular exercise training in different types of GSD. Finally, we consider how oral substrate supplementation can improve exercise tolerance and we discuss the precautions that apply to persons with GSD that engage in exercise.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25326273     DOI: 10.1007/s10545-014-9771-y

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  70 in total

1.  A metabolic myopathy due to absence of muscle phosphorylase.

Authors:  C M PEARSON; D G RIMER; W F MOMMAERTS
Journal:  Am J Med       Date:  1961-04       Impact factor: 4.965

2.  Table of nonprotein respiratory quotient: an update.

Authors:  F Péronnet; D Massicotte
Journal:  Can J Sport Sci       Date:  1991-03

3.  Muscle glycogenosis due to phosphoglucomutase 1 deficiency.

Authors:  Tanya Stojkovic; John Vissing; François Petit; Monique Piraud; Mette C Orngreen; Grete Andersen; Kristl G Claeys; Claire Wary; Jean-Yves Hogrel; Pascal Laforêt
Journal:  N Engl J Med       Date:  2009-07-23       Impact factor: 91.245

4.  Effects of exercise training during infusion on late-onset Pompe disease patients receiving enzyme replacement therapy.

Authors:  Gerasimos Terzis; Argyro Krase; Giorgos Papadimas; Constantinos Papadopoulos; Stavros A Kavouras; Panagiota Manta
Journal:  Mol Genet Metab       Date:  2012-10-24       Impact factor: 4.797

5.  The relative activities attributable to the three phosphoglucomutase loci (PGM1, PGM2, PGM3) in human tissues.

Authors:  P J McAlpine; D A Hopkinson; H Harris
Journal:  Ann Hum Genet       Date:  1970-10       Impact factor: 1.670

Review 6.  Exercise, GLUT4, and skeletal muscle glucose uptake.

Authors:  Erik A Richter; Mark Hargreaves
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

Review 7.  Pompe's disease.

Authors:  Ans T van der Ploeg; Arnold J J Reuser
Journal:  Lancet       Date:  2008-10-11       Impact factor: 79.321

8.  Glucose infusion paradoxically accelerates degradation of adenine nucleotide in working muscle of patients with glycogen storage disease type VII.

Authors:  A Ono; M Kuwajima; N Kono; I Mineo; C Nakagawa; S Tarui; Y Matsuzawa
Journal:  Neurology       Date:  1995-01       Impact factor: 9.910

9.  Abnormal oxidative metabolism and O2 transport in muscle phosphofructokinase deficiency.

Authors:  S F Lewis; S Vora; R G Haller
Journal:  J Appl Physiol (1985)       Date:  1991-01

10.  Paradoxically enhanced glucose production during exercise in humans with blocked glycolysis caused by muscle phosphofructokinase deficiency.

Authors:  J Vissing; H Galbo; R G Haller
Journal:  Neurology       Date:  1996-09       Impact factor: 9.910

View more
  9 in total

1.  Muscle diffusion tensor imaging in glycogen storage disease V (McArdle disease).

Authors:  R Rehmann; L Schlaffke; M Froeling; R A Kley; E Kühnle; M De Marées; J Forsting; M Rohm; M Tegenthoff; T Schmidt-Wilcke; M Vorgerd
Journal:  Eur Radiol       Date:  2018-12-17       Impact factor: 5.315

Review 2.  Skeletal muscle disorders of glycogenolysis and glycolysis.

Authors:  Richard Godfrey; Ros Quinlivan
Journal:  Nat Rev Neurol       Date:  2016-05-27       Impact factor: 42.937

Review 3.  Restoring the regenerative balance in neuromuscular disorders: satellite cell activation as therapeutic target in Pompe disease.

Authors:  Gerben J Schaaf; Rodrigo Canibano-Fraile; Tom J M van Gestel; Ans T van der Ploeg; W W M Pim Pijnappel
Journal:  Ann Transl Med       Date:  2019-07

4.  Effect of administration of high-protein diet in rats submitted to resistance training.

Authors:  Thiago da Rosa Lima; Eudes Thiago Pereira Ávila; Géssica Alves Fraga; Mariana de Souza Sena; Arlyson Batista de Souza Dias; Paula Caroline de Almeida; Joice Cristina Dos Santos Trombeta; Roberto Carlos Vieira Junior; Amílcar Sabino Damazo; James Wilfred Navalta; Jonato Prestes; Fabrício Azevedo Voltarelli
Journal:  Eur J Nutr       Date:  2017-02-24       Impact factor: 5.614

Review 5.  Glycogen metabolism in humans.

Authors:  María M Adeva-Andany; Manuel González-Lucán; Cristóbal Donapetry-García; Carlos Fernández-Fernández; Eva Ameneiros-Rodríguez
Journal:  BBA Clin       Date:  2016-02-27

6.  Exercise efficiency impairment in metabolic myopathies.

Authors:  Jean-Baptiste Noury; Fabien Zagnoli; François Petit; Pascale Marcorelles; Fabrice Rannou
Journal:  Sci Rep       Date:  2020-05-29       Impact factor: 4.379

Review 7.  Update Review about Metabolic Myopathies.

Authors:  Josef Finsterer
Journal:  Life (Basel)       Date:  2020-04-17

8.  Skeletal-Muscle-Specific Overexpression of Chrono Leads to Disruption of Glucose Metabolism and Exercise Capacity.

Authors:  Shiyi He; Lu Yan; Rongxin Zhu; Hao Wei; Jianxiong Wang; Lan Zheng; Ying Zhang
Journal:  Life (Basel)       Date:  2022-08-15

9.  Evaluation of Body Composition, Physical Activity, and Food Intake in Patients with Inborn Errors of Intermediary Metabolism.

Authors:  María-José de Castro; Paula Sánchez-Pintos; Nisreem Abdelaziz-Salem; Rosaura Leis; María L Couce
Journal:  Nutrients       Date:  2021-06-20       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.